EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
批准号:
6173574
负责人:
STEPHAN A. GRUPP
金额:
$22.69万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2004-07-31
关键词:
B lymphocyte apoptosis carcinogenesis cell growth regulation cell proliferation embryo /fetus cell /tissue gene expression genetic susceptibility genetically modified animals immunoprecipitation interferons interleukin 7 laboratory mouse leukemia neoplastic growth neoplastic transformation phosphorylation transfection tyrosine
中文摘要
描述:(逐字改编自研究者摘要)E(-ret
小鼠携带产生嵌合蛋白Rfp-Ret的转基因,
在B谱系细胞中的组成型酪氨酸激酶活性。成年E-ret小鼠
发展出B前体白血病,这些白血病似乎是由
胎儿来源的前B细胞。此外,白血病对刺激有抵抗力,
诱导胎儿和幼年E(-ret)小鼠前B细胞凋亡。的
申请人假设Rfp-Ret产物选择性地增强
胎儿来源的前B细胞的增殖和存活,
转化依赖于其他突变的积累,
进一步增强这些生长特性。该提案的目标是更多
彻底表征E(-ret)中白血病发生的多步骤过程
老鼠.在目标1中,他将确定胎儿和成人的前B细胞是否不同
对Rfp-Ret转基因产物转化的敏感性。他
将胎儿和成年E(-ret pro B细胞转移到Rag-1-小鼠中以确定
这些人群诱发白血病的能力是否不同。在目标2中,
他将确定Rfp-Ret活性是否模拟骨髓的作用,
基质接触他将确定Rag-1小鼠的前B细胞是否获得
当基质细胞表达IL-7时,它们在IL-7中生长而不接触基质细胞的能力
Rfp-Ret产物(E(-ret/Rag-1-)),并将确定Rfp-Ret是否增强
IL-7的增殖作用。在目标3中,他将确定
前B细胞中干扰素(IFN)-β抗性的发展使得
恶性生长他将从晚期肿瘤细胞中分离出抗IFN-β的细胞。
前B细胞群体的健康成年E(-ret小鼠,并测序
IFN-γ抗性细胞的重排免疫球蛋白重链基因座
确定这些细胞是否代表多克隆(未转化)或克隆
(变形)生长。在目标4中,他将确定
Rfp-Ret活性在转化过程中增加。他将
从胎儿和健康人的前B细胞群免疫沉淀Rfp-Ret
成年E(-ret)小鼠以及白血病,并比较酪氨酸水平
Rfp-Ret和Rfp-Ret结合蛋白的磷酸化。
英文摘要
DESCRIPTION: (adapted verbatim from the investigator's abstract) The E(-ret
mouse carries a transgene that produces a chimeric protein, Rfp-Ret with
constitutive tyrosine kinase activity in B lineage cells. Adult E(-ret mice
develop B precursor leukemias that appear to arise from the progeny of
fetal-derived pro B cells. Furthermore, the leukemias are resistant to stimuli
that induce apoptosis in the pro B cells from fetal and young E(-ret mice. The
applicant hypothesizes that the Rfp-Ret product selectively enhances the
proliferation and survival of fetal-derived pro B cells, and that
transformation is dependent on the accumulation of other mutations which
further enhance these growth properties. The goals of this proposal are to more
thoroughly characterize the multistep process of leukemogenesis in the E(-ret
mouse. In aim 1, he will establish whether fetal and adult pro B cells differ
in their susceptibility to transformation by the Rfp-Ret transgene product. He
will transfer fetal and adult E(-ret pro B cells into Rag-1- mice to determine
whether these populations differ in their ability to induce leukemia. In aim 2,
he will establish whether Rfp-Ret activity mimics the effect of bone marrow
stromal contact. He will determine whether pro B cells from Rag-1- mice acquire
the ability to grow in IL-7 without stromal cell contact when they express the
Rfp-Ret product (E(-ret/Rag-1-), and will determine whether Rfp-Ret enhances
the proliferative effect of IL-7. In aim 3, he will establish whether the
development of interferon (IFN)-( resistance in pro B cells allows for
malignant outgrowth. He will isolate IFN-( resistant cells from within the late
pro B cell populations of healthy adult E(-ret mice, and sequence the
rearranged immunoglobulin heavy chain loci of the IFN-( resistant cells to
determine whether these cells represent a polyclonal (nontransformed) or clonal
(transformed) outgrowth. In aim 4, he will establish whether the level of
Rfp-Ret activity increases during the transformation process. He will
immunoprecipitate Rfp-Ret from the pro B cell populations of fetal and healthy
adult E(-ret mice as well as from leukemias and compare the levels of tyrosine
phophorylation of Rfp-Ret and Rfp-Ret-bound proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The cell and gene therapy toolkit for junior faculty
-
批准号:9903575
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2020
-
负责人:STEPHAN A. GRUPP
-
依托单位:
The cell and gene therapy toolkit for junior faculty
-
批准号:10380059
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2020
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7618461
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:8089570
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7406724
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7260150
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7843565
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7424976
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:6920407
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7230434
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7617848
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7054784
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
POST TRANSPLANT T CELL RECONSTITUTION IN NEUROBLASTOMA
-
批准号:6929918
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2004
-
负责人:STEPHAN A. GRUPP
-
依托单位:
POST TRANSPLANT T CELL RECONSTITUTION IN NEUROBLASTOMA
-
批准号:6836914
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2004
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:6377289
-
项目类别:
-
资助金额:$23.37万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:6522280
-
项目类别:
-
资助金额:$24.14万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:6609793
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:2881528
-
项目类别:
-
资助金额:$19.21万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Pediatric Oncology Program
-
批准号:10550223
-
项目类别:
-
资助金额:$8.29万
-
财政年份:1997
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Pediatric Oncology Program
-
批准号:10330968
-
项目类别:
-
资助金额:$8.42万
-
财政年份:1997
-
负责人:STEPHAN A. GRUPP
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: